View Detailed Profile
AAPS PF 101 7 Chemical Stability Assessment in Preformulation: Reid

AAPS PF 101 7 Chemical Stability Assessment in Preformulation: Reid

Description.

AAPS PF 101 2 Drug Substance Physical Form Selection: Vig

AAPS PF 101 2 Drug Substance Physical Form Selection: Vig

Description.

AAPS PF 101 1 Introduction: Preformulation and Biopharmaceutical Considerations in Drug Product

AAPS PF 101 1 Introduction: Preformulation and Biopharmaceutical Considerations in Drug Product

Description.

AAPS PF 101 5 Dissolution and its Role in Solid Oral Dosage Form Development: Amidon

AAPS PF 101 5 Dissolution and its Role in Solid Oral Dosage Form Development: Amidon

Description.

AAPS PF 101 4 Solubility: General Principles and Practical Coniderations: Pinal

AAPS PF 101 4 Solubility: General Principles and Practical Coniderations: Pinal

Description.

AAPS PF 101 3 Drug Substance Physical Form Characterization: Newman

AAPS PF 101 3 Drug Substance Physical Form Characterization: Newman

Description.

AAPS PF 101 8 Excipient Compatibility Studies: Raghavan

AAPS PF 101 8 Excipient Compatibility Studies: Raghavan

Description.

AAPS GOC 8 BCS and BDDCS: Tools to Facilitate Efficiency in Drug Discovery & Development: Benet

AAPS GOC 8 BCS and BDDCS: Tools to Facilitate Efficiency in Drug Discovery & Development: Benet

Description.

Pharmaceutical Quality Assurance and Quality Control (AAPS College)

Pharmaceutical Quality Assurance and Quality Control (AAPS College)

AAPS

APSA 101

APSA 101

This session will provide a basic review and refresher

Orbitrap Based Mass Spectrometric Antibody Drug Conjugate Characterization at AAPS 2015

Orbitrap Based Mass Spectrometric Antibody Drug Conjugate Characterization at AAPS 2015

Stephane Houel, Biopharma Product Marketing Specialist, describes Orbitrap-based mass spectrometric characterization